Growth Metrics

Repligen (RGEN) Liabilities and Shareholders Equity (2016 - 2025)

Repligen (RGEN) has disclosed Liabilities and Shareholders Equity for 15 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 4.24% to $2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.6 billion through Dec 2025, up 2.17% year-over-year, with the annual reading at $2.9 billion for FY2025, 4.24% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $2.9 billion at Repligen, up from $2.9 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $2.9 billion in Q4 2025, with the low at $1.9 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $2.6 billion, with a median of $2.6 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity surged 51.82% in 2021, then dropped 0.05% in 2025.
  • Over 5 years, Liabilities and Shareholders Equity stood at $2.4 billion in 2021, then grew by 7.35% to $2.5 billion in 2022, then rose by 11.83% to $2.8 billion in 2023, then fell by 0.05% to $2.8 billion in 2024, then rose by 4.24% to $2.9 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $2.9 billion, $2.9 billion, and $2.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.